ERT Adds Centralized Data Surveillance for Respiratory Trials

Article

Applied Clinical Trials

Features of the Centralized Data Surveillance include: • Assessing protocol risks, needs and key performance metrics such as site proficiency, calibration, rest between maneuvers, protocol adherence, acceptable/unacceptable Best Test Review data errors impacting the start of tests, and amount of data with repeatability issues

ERT, a global provider of patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions announced Centralized Data Surveillance to support Risk-Based Monitoring in respiratory clinical research.

Features of the Centralized Data Surveillance include:

  • Assessing protocol risks, needs and key performance metrics such as site proficiency, calibration, rest between maneuvers, protocol adherence, acceptable/unacceptable Best Test Review data errors impacting the start of tests, and amount of data with repeatability issues

  • Analyzing endpoint data in near real-time to continuously fine-tune the monitoring strategy

  • Supporting or executing an intervention plan to address risks and data deviations as they arise, targeting sites for training, on-site monitor visits and other interventions to boost data quality

Read the full release.

 

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.